Attached files
file | filename |
---|---|
EX-10.20 - EXHIBIT 10.20 - Travere Therapeutics, Inc. | ex1020-1231201710k.htm |
EX-32.2 - EXHIBIT 32.2 - Travere Therapeutics, Inc. | ex322-1231201710k.htm |
EX-32.1 - EXHIBIT 32.1 - Travere Therapeutics, Inc. | ex321-1231201710k.htm |
EX-31.2 - EXHIBIT 31.2 - Travere Therapeutics, Inc. | ex312-1231201710k.htm |
EX-31.1 - EXHIBIT 31.1 - Travere Therapeutics, Inc. | ex311-1231201710k.htm |
EX-23.1 - EXHIBIT 23.1 - Travere Therapeutics, Inc. | ex231-1231201710k.htm |
10-K - 10-K - Travere Therapeutics, Inc. | rtrx-20171231x10k.htm |
EX
Exhibit 21.1
RETROPHIN, INC.
LIST OF SUBSIDIARIES
No. | Name | |
1 | Retrophin Pharmaceutical, Inc. | |
2 | Retrophin Therapeutics I, Inc. | |
3 | Retrophin Therapeutics II, Inc. | |
4 | Retrophin Europe Ltd | |
5 | Retrophin International Holdings Ltd | |
6 | RTRX International CV | |
7 | Retrophin Therapeutics International LLC | |
8 | US LLC 2 | |
9 | Retrophin Research Ltd | |
10 | Retrophin US Holdings LLC | |
11 | Manchester Pharmaceuticals LLC |